Company

VETmAb Biosciences, Inc.

Biotechnology Research San Diego, Ca, United States 5 employees

Employees: 5
Contacts: 3
Emails: 3
Phones: 3

www.vetmab.bio LinkedIn

VETmAb Biosciences, Inc. Overview

Headquarters: San Diego, Ca, United States
Website: www.vetmab.bio
Industry: Biotechnology Research
Employees: 5
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Animal Health Monoclonal Antibodies Veterinary Medicine Biotechnology

About VETmAb Biosciences, Inc.

VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine. At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine. Our team is comprised of experts who have decades of collective experience in mAb technology and animal health. Learn more: https://www.vetmab.bio/about/

VETmAb Biosciences, Inc. Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

VETmAb Biosciences, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kristy Longpre, Phd, PMP	Director of Operations at Vetmab Bio	United States	Email Phone
Denise Bevers	Founder & CEO, Vetmab Bio - Board Member - Philanthropist - Advisor	San Diego, California, United States	Email Phone
Chrysa Mineo	Director, Cidara Therapeutics	San Diego, California, United States	Email Phone
Richard Chin	CEO of Ambrosia Biolongevity - Managing Director of Ascendant Venture - Blogs at Richardychin.medium.com and Clinicaltrialist.com		View